Main Menu

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read our statement on the NICE ruling on abiraterone and find out more about our discovery of a key mutation which causes a childhood kidney cancer.

Back to top
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.